[Plasma cell leukaemia. Haematological features and response to treatment (author's transl)].
D000368:Aged; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007952:Leukemia, Plasma Cell / Q000188:drug therapy / Q000276:immunology* / Q000401:mortality; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D010266:Paraproteins / Q000032:analysis*; D011241:Prednisone / Q000627:therapeutic use
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D010266:Paraproteins; D008558:Melphalan; D011241:Prednisone
Leucemia de células plasmáticas. Aspectos hematológicos y respuesta al tratamiento